• AXIS Clinicals successfully completes 14th US FDA audit (June 2016)
  • AXIS Clinicals successfully completes US FDA audit for ICP-OES services (March 2016)
  • AXIS Clinicals successfully completes 7th ANVISA – Brazil audit (March 2015)
  • AXIS Clinicals successfully completes WHO audit (March 2015)
  • AXIS Clinicals successfully completes 3rd MHRA audit (Sep 2014)
  • BA-BE studies conducted at AXIS Clinicals are accepted by Chile – ISP

Events in 2016

CPhI China 2016

  • June 21 - 23, 2016
    Shanghai New Int'l Expo Centre (SNIEC), Shanghai, China

CPhI Korea 2016

  • 23-25 August 2016
    COEX Hall D, Seoul, Korea

CPhI Worldwide 2016

  • 4th-6th October, 2016
    Fira de Barcelona Gran Via, Barcelona, Spain

CPhI India 2016

  • 21 - 23 November 2016
    Bombay Exhibition Centre & MMRDA Grounds, BKC, Mumbai, India

 


Fact sheet

  • Over 1,600 clinical studies completed since inception
  • Over 290 bioanalytical methods developed
  • Over 38 successful Regulatory audits
  • Global footprint of operations with sites in India, U.S, Mexico & Thailand.
  • Two clinical facilities in India
  • 60+ National and International Pharma/Biotech Sponsor companies working with AXIS
  • US FDA : 200+ approvals, EMEA : 70+ approvals, Canada : 20+ approvals, Australia : 30+ approvals
  • 350+ staff working globally
  • Huge database of patient population in various therapeutic areas viz. Cardiology, Opthalmology, Schizophrenia, Diabetology, Oncology. Orthopedics etc..

Copyright Axis Clinicals - All Rights Reserved

Design By Graypixel